Drug Research
Next Generation Proteomics Excel Singapore Precision Drugs
The National University of Singapore’s Yong Loo Lin School of Medicine has gone on to launch the NUS Medicine Protein Biomarker Discovery Core Facility, which will hand out the Olink Target 96 and 48, Olink Explore 3072, as well...
Drug Research
Guidance On mAbs, Therapeutic Proteins Potency Issued By FDA
The FDA has gone on to issue guidance on March 2, 2023 in order to give out recommendations to sponsors that will help in monoclonal antibodies- mAbs creation as well as other therapeutic proteins which go on to target...
Drug Research
Protein Drug Manufacturing May Get New Purification Method
In a recent study, researchers at the Massachusetts Institute of Technology (MIT) have come up with a new purification approach to reduce the cost of making protein drugs. So as to isolate proteins from a bioreactor rapidly and cheaply,...
Drug Research
IAVI, BARDA Expand Partnership to Advance Filovirus Vaccine Candidates
International AIDS Vaccine Initiative (IAVI) announced the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, funded additional development and testing of IAVI's...
Drug Research
NIIMBL Unveils 3 New Vaccine Manufacturing Projects
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has announced approximately $1.7 million in planned project activities through the Institute's Global Health Fund (GHF) Project Call 6.1G for three new projects focused on the development of in vitro...
Drug Research
AtomVie Builds Radiopharmaceutical CDMO Facility
AtomVie Global Radiopharma has signed a lease agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated to high volume clinical and commercial GMP manufacturing and worldwide distribution of...
Drug Research
Novo Nordisk to Expand R&D Presence in Greater Boston Area
Novo Nordisk plans to expand its R&D presence in the greater Boston area, creating one of its largest R&D hubs outside of Denmark. The new hub, which will leverage the company’s existing presence in Lexington, Cambridge and Watertown, MA,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















